Pat Dorsey's top dividend stocks for April 2026 include Royalty Pharma plc (RPRX), a leading acquirer of biopharmaceutical royalties and funder of innovation in the biopharmaceutical industry.

Pat Dorsey is a renowned investor and the founder of Dorsey Asset Management, an investment firm focused on identifying high-quality businesses with durable competitive advantages. His investment philosophy centers on understanding a company's economic moat, which is its structural characteristic that protects its long-term profitability and market share from competitive forces.

Royalty Pharma plc (RPRX)

Royalty Pharma is a pioneer in the field of funding innovation in the biopharmaceutical industry. The company acquires royalty interests in pharmaceutical products, providing capital to the biopharma sector while offering investors exposure to breakthrough medical advancements.

In Pat Dorsey's portfolio, this position currently holds a value of $108.39 million. Investors considering this stock might note its trailing twelve-month dividend rate of $0.90, alongside a dividend yield of approximately 1.93%. Furthermore, analyst projections set a price target around $51.25, with a discounted cash flow valuation pointing to $117.4.

Here's an overview of Pat Dorsey's trades in Royalty Pharma plc:

Booking Holdings Inc (BKNG)

Booking Holdings is a global leader in online travel and related services, offering everything from hotel bookings to rental cars and airline tickets. Its portfolio of brands, including Booking.com, Priceline, Agoda, and Kayak, serves millions of travelers worldwide.

The current value of this holding within Pat Dorsey's portfolio is $68.7 million. This stock currently yields about 0.97% in dividends, reflecting a trailing twelve-month dividend payout of $39.30. Analysts have set an average price target of $5.91K, and a discounted cash flow analysis suggests a value of $6.04K.

Here's an overview of Pat Dorsey's trades in Booking Holdings Inc:

Aercap Holdings N.V. (AER)

AerCap Holdings is the world's largest independent aircraft leasing company, owning and managing a diverse portfolio of commercial aircraft. They provide comprehensive fleet solutions to airlines globally, from wide-body to narrow-body aircraft.

Pat Dorsey's position in AerCap Holdings is valued at $166.68 million. Shareholders receive a trailing twelve-month dividend rate of $1.21, translating to a dividend yield of around 0.91%. The consensus analyst price target for the stock is approximately $165.33.

Here's an overview of Pat Dorsey's trades in Aercap Holdings N.V.:

Danaher Corp. (DHR)

Danaher Corporation is a global science and technology innovator with a broad portfolio of leading brands in diagnostics, life sciences, and environmental & applied solutions. The company's products and services are critical for advancing research, improving patient health, and ensuring environmental quality.

Within Pat Dorsey's holdings, the Danaher position is currently worth $156.9 million. The stock offers a dividend yield of roughly 0.75% based on its trailing twelve-month dividend rate of $1.68. Analysts generally project a price target of $257.50, and a discounted cash flow valuation stands at $163.69.

Here's an overview of Pat Dorsey's trades in Danaher Corp.:

ASML Holding NV (ASML)

ASML Holding is a Dutch multinational corporation specializing in the development and manufacturing of photolithography systems. These systems are crucial for producing integrated circuits (microchips) and are used by major chipmakers worldwide.

Pat Dorsey's portfolio holds $254.05 million in ASML shares. The company pays a trailing twelve-month dividend rate of $6.97, resulting in a dividend yield of about 0.56%. The average analyst price target is $1.59K, with a discounted cash flow suggesting a value of $530.05.

Here's an overview of Pat Dorsey's trades in ASML Holding NV: